Suomen Solubiologit ry

Yhdistys edistää solubiologian tutkimusta, koulutusta, tiedotusta ja työpaikkojen perustamista solubiologeille harjoittaen koulutus- ja tiedotustoimintaa.

Liity jäseneksi

Ajankohtaista

Syöpäsolujen filopodien tärkeä rooli syövän leviämisessä

15.1.2019 | Uutiset

https://www.hs.fi/tiede/art-2000005965442.html

Tänään Helsingin Sanomissa: Professori Johanna Ivaska ja tutkijatohtori Guillaume Jacquemet kertovat syöpäsolujen filopodeista, jotka ”tarkastelevat” solun ympärillä olevien kudosten ominaisuuksia aktiivisesti ja ovat siten erittäin tärkeitä syöpäkasvaimen leviämisessä. Tutkijoiden tavoitteena on löytää lääkeaine, joka estää filopodien päistä löytyvän myosiini-10:n toiminnan ja sen kautta syöpäsolun etenemisen.

A post-doctoral position in the Pravetoni lab at the University of Minnesota Medical School

9.1.2019 | Avoimet työpaikat

A post-doctoral position in the Pravetoni lab at the University of Minnesota Medical School is available immediately for individuals interested in development of immunotherapies to reduce opioid use disorders and opioid-related overdoses. Our unique multidisciplinary research program integrates rational vaccine design, immunomodulators, formulation/delivery platforms, pre-clinical models, analysis of B and T cell lymphocyte repertoire, GLP/GMP studies to support regulatory approval and clinical evaluation, and ad hoc industry collaborations.

Our team is currently planning Phase I clinical trials of vaccines targeting heroin and oxycodone. Strategies and platforms will be applied to development of vaccines or antibodies against emerging pathogens, and agents of bioterrorism or chemical warfare.

We are seeking an independent and motivated colleague interested in leading multidisciplinary projects  as well as team efforts. For our recent publications search PubMed for “Pravetoni M”. Posting can be found at:  https://hr.myu.umn.edu/jobs/ext/328252.

Postdoctoral researcher or project researcher to study new regulators of the immune system through single-cell omics in Molecular Systems Immunology Group at Turku Centre for Biotechnology

9.1.2019 | Avoimet työpaikat

Our international multidisciplinary research group (https://www.btk.fi/research/molecular-systems-immunology/) led by Academy Professor Riitta Lahesmaa is based at Turku Centre for Biotechnology (the Centre), BioCity Turku, Turku, Finland.  We are seeking for a motivated postdoctoral researcher or project researcher with possibility to continue work as a doctoral candidate.

Disorders in immune system and lymphocyte function lead to inflammatory diseases e.g. rheumatoid arthritis and Type 1 Diabetes. Project will focus on studying the molecular mechanisms underlying immune mediated diseases aiming at enabling individualized treatment in the future.

Description of recruiting organization

Molecular Systems Immunology group aims at understanding the regulation of human immune system to predict, prevent and treat immune mediated disorders. We study epigenetic and transcriptional regulation of T cells and molecular mechanisms of immune mediated diseases.

Turku Centre for Biotechnology is a joint research institute of University of Turku and Åbo Akademi University. The mission of the Centre is to promote high quality research and training. The Centre has excellent state-of-the-art technology platforms and expertise in single-cell omics, next-generation sequencing, epigenomics, proteomics, computational biology and high-end cell imaging.

Project

The project aims at understanding how novel regulators of immune system, recently discovered by our group, act on a molecular level. We will use cutting-edge single-cell omics tools, i.e. single cell sequencing and mass cytometry. We will collaborate closely with Dr. Tapio Lönnberg, an in-depth expert in single-cell omics and head of our Centre’s single-cell omics facility. Our key collaborator is Research Director  Laura Elo and her group, the Medical Bioinformatics Centre, who have developed novel tools to analyses single-cell omics data.

Qualifications, successful candidates have:

  • A relevant doctor’s degree (postdoctoral researcher) or a relevant master’s degree (project researcher) e.g. in life sciences or in biomedicine
  • High level of motivation, self-initiative and independency
  • Excellent team work and communication skills in English (both oral and written)
  • First-rate molecular and cell biology knowledge and skills
  • Strong publication record in international journals (postdoctoral researcher) at least in one of the following areas: immunology, molecular and cellular biology, autoimmunity, genetics, epigenetics.

Application

The salary is in accordance with the University salary system (for teaching and research personnel) level 5 (postdoctoral researcher) where the work specific salary component is 2 903,61 €/month or  levels 3-4 (project researcher),  where the work specific salary component is 2 209,17 – 2507,62 €/month. In addition, there is a share increase based on the personal performance, which is, at most, 50% of the base salary. The position starts at earliest on March 1st, 2019 (or as agreed). The positions are initially for two years, one optional year possible. There is a trial period of six months.

The deadline for applications is Jan 31, 2019 (23:59). A link to the electronic application system can be found from the following link: https://www.utu.fi/en/university/come-work-with-us/open-vacancies

Please include a CV, full publication list, list of selected publications and contact information for three references in your application.

For further information on the positions please contact: Prof. Riitta Lahesmaa, e-mail: riitta.lahesmaa@btk.fi  . Enquiries on the application procedure may be directed to Human Resources Specialist Paula Luoma, paula.luoma@utu.fi .

Solubiologi-lehti

6.11.2018

Solubiologi-lehti etsii toimittajaa Oulusta!

Oletko kiinnostunut tieteellisestä kirjoittamisesta? Kaksi kertaa vuodessa ilmestyvä Solubiologi-lehti etsii uutta toimittajaa Oulusta! Kiinnostuneet voivat ottaa yhteyttä lehden päätoimittajaan, Jenny Joutseneen, jenny.joutsen@abo.fi!